NEWS		FONAR Corporation
For Immediate Release		The Inventor of MR Scanning™
Contact: Daniel Culver		An ISO 9001 Company
Director of Communications		Melville, New York 11747
E-mail: investor@fonar.com		Phone: (631) 694-2929
www.fonar.com		Fax: (631) 390-1772

Raymond Vahan Damadian, The Father of MRI, Chairman and Founder of FONAR Corporation, dies at 86

MELVILLE, NEW YORK, August 5, 2022 - FONAR Corporation (NASDAQ-FONR), The Inventor of MR Scanning™, reported today the passing of Founder and Chairman Raymond V. Damadian, MD on August 3, 2022.

Highlights of the life of Dr. Raymond Damadian:

Timothy Damadian, Dr. Damadian's son and President and CEO of FONAR issued the following statement: “Dr. Damadian was a husband, a father, a grandfather, a great grandfather, a brother, an uncle, and a friend to many. He leaves behind three adoring children, nine grandchildren, and three great grandchildren.

Mr. Damadian continued: “In his 86 years of life, Dr. Damadian accomplished more than most could dream of. He was born in March 1936 to Vahan and Odette Damadian, both Armenian-Americans. He spent his childhood in Forest Hills, New York playing with and watching over his younger sister, Claudette. He studied violin at Julliard until winning a Ford Foundation scholarship to the University of Wisconsin at the young age of 15. After graduating college with a degree in mathematics, he went on to Albert Einstein College of Medicine and earned his medical degree. Soon after graduating from medical school, he married Donna Terry, who passed away in 2020.  

“As a newly minted physician, Dr. Damadian joined the faculty at SUNY Downstate in Brooklyn. New York. It was there that he began the long and arduous journey that would ultimately lead to the invention of the MRI. While working on a research project he came across a tool used by chemists called nuclear magnetic resonance (NMR). NMR was able to detect signals from the contents of a test tube in order to help identify the contents’ chemical makeup. Stunned by this tool, which scientists had been using for years, he imagined using it on a much larger scale to look inside the body instead of just a test tube. Dr. Damadian's hard work, perseverance, and unwavering faith in God transformed this figment of his imagination into the first MRI machine.

“Throughout all of the trials and tribulations he encountered while achieving this revolutionary medical breakthrough, Dr. Damadian never gave up on his dream. His persistence in the face of great adversity, especially among the scientific community, and his intense passion for trying to cure cancer led to the invention of a machine that has undoubtedly impacted and saved millions of lives. July 3, 1977 was the day he and his team achieved the world’s first human MRI scan from the machine that they had named Indomitable.

“Dr. Damadian decided to take his invention and start his own business – FONAR. The company, which was incorporated in 1978, sold its first commercial MRI scanner in 1980. For over 40 years, Dr. Damadian poured his heart and soul into this company.

“Today the world mourns the loss of the Father of MRI. Dr. Damadian was a brilliant inventor, a compassionate physician, a devoted husband, a loving father, grandfather, and great-grandfather, and a trusted friend.

“While my father’s guidance, experience, wisdom and day-to-day presence will be sorely missed, I am confident that the management team that had earned his trust over the last twelve years will keep FONAR profitable for years to come.

About FONAR

FONAR, the Inventor of MR Scanning™, located in Melville, NY, was incorporated in 1978, and is the first, oldest and most experienced MRI company in the industry. FONAR introduced the world’s first commercial MRI in 1980, and went public in 1981. FONAR’s signature product is the FONAR UPRIGHT® Multi-Position™ MRI (also known as the STAND-UP® MRI), the only whole-body MRI that performs Position™ Imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® MRI often detects patient problems that other MRI scanners cannot because they are lie-down, “weightless-only” scanners. The patient-friendly UPRIGHT® MRI has a near-zero patient claustrophobic rejection rate. As a FONAR customer states, “If the patient is claustrophobic in this scanner, they’ll be claustrophobic in my parking lot.” Approximately 85% of patients are scanned sitting while watching TV.

FONAR has new works-in-progress technology for visualizing and quantifying the cerebral hydraulics of the central nervous system, the flow of cerebrospinal fluid (CSF), which circulates throughout the brain and vertebral column at the rate of 32 quarts per day. This imaging and quantifying of the dynamics of this vital life-sustaining physiology of the body’s neurologic system has been made possible first by FONAR’s introduction of the MRI and now by this latest works-in-progress method for quantifying CSF in all the normal positions of the body, particularly in its upright flow against gravity. Patients with whiplash or other neck injuries are among those who will benefit from this new understanding.

FONAR’s primary source of income and growth is attributable to its wholly-owned diagnostic imaging management subsidiary, Health Management Company of America (HMCA) www.hmca.com.

FONAR’s substantial list of patents includes recent patents for its technology enabling full weight-bearing MRI imaging of all the gravity sensitive regions of the human anatomy, especially the brain, extremities and spine. It includes its newest technology for measuring the Upright cerebral hydraulics of the cerebrospinal fluid (CSF) of the central nervous system. FONAR’s UPRIGHT® Multi-Position™ MRI is the only scanner licensed under these patents.

UPRIGHT® and STAND-UP® are registered trademarks. The Inventor of MR Scanning™, CSP™,  Multi-Position™, UPRIGHT RADIOLOGY™, The Proof is in the Picture™, pMRI™,  CSF Videography™,  and Dynamic™ are trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company's financial results may be found in the company's filings with the Securities and Exchange Commission.